What is Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Annual Net Profit?

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Annual Net Profit rose 100.09% in the last year to $0.88 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Price to Earning Ratio?

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Price to Earning Ratio is -3, which is negative.

What is Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Quarterly Revenue?

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Quarterly Revenue fell 45.05% YoY to $41.14 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Quarterly Net profit?

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Quarterly Net profit fell 798.27% YoY to $37.39 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Mutual Fund Holding?

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Mutual Fund Holding decreased by 8.38% in the last quarter to 35.63.

What is Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Promoter Share Holding?

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Promoter Share Holding increased by 0.49% in the most recent quarter to 3.1%.

What is Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Interest Coverage Ratio?

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Interest Coverage Ratio is 2.97, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Institutional Holding?

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Institutional Holding decreased by 3.81% in the last quarter to 97.49.

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A XNAS: IRWD

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A
Rating: 1.34833325
Author: Trendlyne DVM scores

about

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome ...

0.60 -0.03 (-4.76%)

91.55% Fall from 52W High

4.3M XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Not Eligible

-

Mid Valuation

32.3 / 100

Technically Bearish

21.6 / 100

1

1Yr Price target upside is 58%

4 analysts

Ironwood Pharmaceuticals I... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A FAQ

How is Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A today?

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A today is trading in the red, and is down by -4.76% at 0.60.

How has Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A performed historically?

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A is currently trading down -4.76% on an intraday basis. In the past week the stock rose 5.26%. stock has been down -62.73% in the past quarter and fell -90.48% in the past year. You can view this in the overview section.